Study tracking sugar and immune cells in ovarian cancer fluid
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study uses a trace amount of glucose (a type of sugar) to see how tumor cells and immune cells behave inside the fluid that collects with ovarian cancer (ascites). It may help researchers understand what drives cancer activity and immune responses, which could guide better treatments in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have ovarian cancer
- You have ascites (fluid buildup) that needs to be drained
- You can sign informed consent and understand the study
- You do not have diabetes, or abnormal A1C (a blood test for average sugar levels)
- Your blood sugar is in a normal range (about 4 to 11.1 mM) before the glucose infusion
- You are not receiving chemotherapy during the 5 hours of the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at fluid from the belly (ascites) in people with ovarian cancer to understand it better. It only includes women who are having surgery to remove as much cancer as possible.
This laboratory study uses ovarian cancer fluid collected during surgery to test possible new treatments on cancer and immune cells. It may help researchers find better treatment options in ovarian cancer.
This study looks for cancer DNA in your blood to understand advanced ovarian cancer better. It helps doctors see how the disease changes over time and may improve future treatments.
This study looks at what makes some cancers more “noticeable” to the immune system. It may help researchers design better future immunotherapy by collecting information (often including blood samples) from people with different cancers.
This study uses lab testing to create a “map” of ovarian cancer cells one cell at a time, to better understand the disease. It likely helps researchers learn which cell types are involved, using samples collected around your surgery.
This study is testing a blood test to see if it can catch ovarian cancer early. You may be eligible if you have been recently diagnosed with ovarian cancer and haven't started treatment yet.
Hear when a new Ovarian cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.